{"id":32244,"date":"2023-01-26T11:06:58","date_gmt":"2023-01-26T10:06:58","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=32244"},"modified":"2023-01-24T12:09:12","modified_gmt":"2023-01-24T11:09:12","slug":"anaemie-bei-chronischen-entzuendungen-traegt-besseres-verstaendnis-pathophysiologischer-mechanismen-zur-entwicklung-neuer-medikamentoeser-therapieoptionen-bei-cme","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2023\/anaemie-bei-chronischen-entzuendungen-traegt-besseres-verstaendnis-pathophysiologischer-mechanismen-zur-entwicklung-neuer-medikamentoeser-therapieoptionen-bei-cme","title":{"rendered":"An\u00e4mie bei chronischen Entz\u00fcndungen: Tr\u00e4gt besseres Verst\u00e4ndnis pathophysiologischer Mechanismen zur Entwicklung neuer medikament\u00f6ser Therapieoptionen bei? [CME]"},"content":{"rendered":"<p>Eisenmangel (\u201eIron Deficiency Anemia\u201c = IDA) und Aktivierung des Immunsystems (\u201eAnemia of Inflammation\u201c = AI bzw. \u201eAnemia of Chronic Disease\u201c = ACD) gelten heute als h\u00e4ufigste Ursachen der An\u00e4mie infolge einer St\u00f6rung der Eisenhom\u00f6ostase , , , , , . Die IDA beruht auf einer Verminderung des Gesamtk\u00f6rpereisens, meist als Folge von Blutverlust, unzureichender aliment\u00e4rer [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eisenmangel (\u201eIron Deficiency Anemia\u201c = IDA) und Aktivierung des Immunsystems (\u201eAnemia of Inflammation\u201c = AI bzw. \u201eAnemia of Chronic Disease\u201c = ACD) gelten heute als h\u00e4ufigste Ursachen der An\u00e4mie infolge einer St\u00f6rung der Eisenhom\u00f6ostase , , , , , . Die IDA beruht auf einer Verminderung des Gesamtk\u00f6rpereisens, meist als Folge von Blutverlust, unzureichender aliment\u00e4rer [&hellip;]<\/p>\n","protected":false},"author":9020,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1279,463,1188,1547,5790,1615,1608,1540,5792,1549,1267,5791,5794,1977,5793,1538],"class_list":["post-32244","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-anaemie","tag-chronisch-entzuendliche-darmerkrankungen","tag-colitis-ulcerosa","tag-eisen","tag-entzuendung","tag-erythropoese-stimulierende-wirkstoffe","tag-erythropoietin","tag-ferritin","tag-ferroportin","tag-hepcidin","tag-infliximab","tag-morbus-crohn","tag-roxadustat","tag-tocilizumab","tag-transferrin","tag-transferrin-saettigung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/32244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/9020"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=32244"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/32244\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=32244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=32244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=32244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}